lexatumumab (ETR2-ST01) / GSK  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
lexatumumab (ETR2-ST01) / GSK
NCT00428272: HGS-ETR2 to Treat Children With Solid Tumors

Terminated
1
30
US
Lexatumumab alone, Lexatumumab in combination, Interferon gamma 1b in combination, Gamma 1b potential expansion
National Cancer Institute (NCI)
Ewing's Sarcoma, Osteosarcoma, Neuroblastoma, Rhabdomyosarcoma
04/11
10/15

Download Options